Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trial (NCT00077883). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from TLK286 and cisplatin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trial (NCT00077883). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trial (NCT00077883). Contact the study team or your healthcare provider for specific answers.

Question 4

What criteria will determine if I am eligible to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trial (NCT00077883). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks involved in this combination treatment that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trial (NCT00077883). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trial (NCT00077883). Contact the study team or your healthcare provider for specific answers.

What this study is about